DexCom Inc (DXCM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:DexCom Inc (DXCM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7366
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring systems. DexCom’s in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also provides training and support services. DexCom offer its products to endocrinologists, physicians, diabetes educators and others. The company distributes its products in the US, Canada, Australia, New Zealand, Europe, Asia, Latin America and the Middle East through direct sales force and a network of distributors. DexCom is headquartered in San Diego, California, the US.

DexCom Inc (DXCM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
DexCom Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
DexCom Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
DexCom Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
DexCom Inc, Medical Equipment, Deal Details 12
Venture Financing 12
DexCom Raises USD7.2 Million in Venture Financing 12
TypeZero Technologies Raises Funds through Seed Financing 13
Partnerships 14
TypeZero Technologies and EOFlow Enter into Licensing Agreement 14
Senseonics Enters into Licensing Agreement with TypeZero Tech 15
Cellnovo Enters into Licensing Agreement with TypeZero Tech 16
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 17
Dexcom Amends Licensing Agreement with Google Life Sciences 18
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 19
Tandem Diabetes Amends Licensing Agreement With DexCom 20
Novo Nordisk Forms Partnership with Dexcom and Glooko 21
Terumo Enters into Distribution Agreement with DexCom 22
DexCom Enters into Agreement with Eli Lilly 23
Fitbit Forms Partnership with DexCom 24
Senseonics Holdings Enters into Agreement with TypeZero and Roche Diabetes 25
Ascensia Diabetes Care Enters into Agreement with DexCom 26
Apple Enters into Agreement with DexCom 27
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 28
Glooko Enters into Agreement with Dexcom 29
Julphar Enters Into Co-Marketing Agreement With Dexcom 30
Debt Offering 31
DexCom Raises USD350 Million in Private Placement of 0.75% Notes Due 2022 31
Acquisition 32
DexCom Acquires TypeZero Technologies 32
DexCom to Acquire Nintamed 33
DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To USD8.5 Million 34
DexCom Inc – Key Competitors 35
DexCom Inc – Key Employees 36
DexCom Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Financial Announcements 38
Aug 01, 2018: DexCom Reports Second Quarter 2018 Financial Results 38
Feb 27, 2018: DexCom Reports Record Fourth Quarter and Fiscal Year 2017 Financial Results 39
Nov 01, 2017: DexCom Reports Record Third Quarter 2017 Financial Results 41
Aug 01, 2017: DexCom Reports Second Quarter 2017 Financial Results 42
May 02, 2017: DexCom Reports First Quarter 2017 Financial Results 43
Feb 28, 2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results 44
Jan 10, 2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook 45
Corporate Communications 46
Aug 01, 2018: DexCom Executive Chairman and Director Terry Gregg Retires 46
Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors 47
Legal and Regulatory 48
Jun 05, 2018: Federal Court Judge Awards AgaMatrix Attorneys’ Fees While Admonishing Dexcom for “Bad Faith” Lawsuit 48
Product News 49
Aug 21, 2017: New Study Shows People with Type 2 Diabetes Benefit from Continuous Glucose Monitoring 49
Jun 09, 2017: New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Daily Injections Benefit from CGM 50
Other Significant Developments 52
Sep 19, 2017: DexCom Opens Data Platform and Launches Developer Program to Fuel Diabetes App Innovation 52
Sep 07, 2017: Fitbit and Dexcom to Develop Continuous Glucose Monitoring Experience for People Living with Diabetes 53
Jun 01, 2017: Glooko and Dexcom Expand Relationship With Global Cloud Sharing Data Agreement 54
May 08, 2017: Dexcom Continuous Glucose Monitoring now available on the Government Subsidy Initiative 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
DexCom Inc, Medical Equipment, Key Facts, 2017 2
DexCom Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
DexCom Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
DexCom Inc, Deals By Market, 2012 to YTD 2018 9
DexCom Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
DexCom Raises USD7.2 Million in Venture Financing 12
TypeZero Technologies Raises Funds through Seed Financing 13
TypeZero Technologies and EOFlow Enter into Licensing Agreement 14
Senseonics Enters into Licensing Agreement with TypeZero Tech 15
Cellnovo Enters into Licensing Agreement with TypeZero Tech 16
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 17
Dexcom Amends Licensing Agreement with Google Life Sciences 18
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 19
Tandem Diabetes Amends Licensing Agreement With DexCom 20
Novo Nordisk Forms Partnership with Dexcom and Glooko 21
Terumo Enters into Distribution Agreement with DexCom 22
DexCom Enters into Agreement with Eli Lilly 23
Fitbit Forms Partnership with DexCom 24
Senseonics Holdings Enters into Agreement with TypeZero and Roche Diabetes 25
Ascensia Diabetes Care Enters into Agreement with DexCom 26
Apple Enters into Agreement with DexCom 27
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 28
Glooko Enters into Agreement with Dexcom 29
Julphar Enters Into Co-Marketing Agreement With Dexcom 30
DexCom Raises USD350 Million in Private Placement of 0.75% Notes Due 2022 31
DexCom Acquires TypeZero Technologies 32
DexCom to Acquire Nintamed 33
DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To USD8.5 Million 34
DexCom Inc, Key Competitors 35
DexCom Inc, Key Employees 36
DexCom Inc, Subsidiaries 37

List of Figures
DexCom Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
DexCom Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
DexCom Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
DexCom Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[DexCom Inc (DXCM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suzlon Energy Limited:企業の戦略・SWOT・財務分析
    Suzlon Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Suzlon Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • TheraDiag SA (ALTER):企業の財務・戦略的SWOT分析
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • TrueBlue Inc (TBI):企業の財務・戦略的SWOT分析
    Summary TrueBlue Inc (TrueBlue) is a talent solution company that provides filling individual positions on demand, staffing entire facilities and managing outsourced recruiting processes and staffing vendor programs. The company business division includes People Ready, Workforce Management and Peopl …
  • The Blackstone Group LP:戦略・SWOT・企業財務分析
    The Blackstone Group LP - Strategy, SWOT and Corporate Finance Report Summary The Blackstone Group LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • A.P. Eagers Ltd:企業の戦略・SWOT・財務分析
    A.P. Eagers Ltd - Strategy, SWOT and Corporate Finance Report Summary A.P. Eagers Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Micro Labs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, aml …
  • Drake & Scull International (DSI):企業の財務・戦略的SWOT分析
    Drake & Scull International (DSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Stealth BioTherapeutics Corp (MITO):企業の戦略的SWOT分析
    Stealth BioTherapeutics Corp (MITO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Greif, Inc.:戦略・SWOT・企業財務分析
    Greif, Inc. - Strategy, SWOT and Corporate Finance Report Summary Greif, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Heraeus Holding GmbH:企業の戦略・SWOT・財務情報
    Heraeus Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Heraeus Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Pt Bakrieland Development Tbk
    Pt Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • China Ming Yang Wind Power Group Ltd-エネルギー分野:企業M&A・提携分析
    Summary China Ming Yang Wind Power Group Limited (Ming Yang) is a wind equipment company that designs, manufactures, sells and services wind turbines. It also provides services such as technical training, transportation of wind turbines, installation of wind turbines, debugging service of wind gener …
  • NewOcean Energy Holdings Ltd (342):企業の財務・戦略的SWOT分析
    NewOcean Energy Holdings Ltd (342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kerry Group plc:戦略・SWOT・企業財務分析
    Kerry Group plc - Strategy, SWOT and Corporate Finance Report Summary Kerry Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • LifeAssays AB (LIFE B)-医療機器分野:企業M&A・提携分析
    Summary LifeAssays AB (LifeAssays) is a medical device company that develops, manufactures and markets in-vitro diagnostic and veterinary care products. The company provides point-of-care diagnostic testing systems. Its product portfolio includes lifeassays human system and lifeassays veterinary sys …
  • Millennium & Copthorne Hotels Plc:戦略・SWOT・企業財務分析
    Millennium & Copthorne Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Millennium & Copthorne Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Wintac Ltd (524758):製薬・医療:M&Aディール及び事業提携情報
    Summary Wintac Ltd (Wintac), formerly Recon Ltd is a manufacturer and marketer of sterile products. The company offers opthalmic products such as anti-glaucoma, anti-cholinergic, artificial tear, NSAID, steroids and combination, anti-infective, decongestant, anti allergic eye drops and nasal drop, a …
  • Taiwan Semiconductor Manufacturing Company Limited
    Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report Summary Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Neusoft Medical Systems Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Neusoft Medical Systems Co Ltd (Neusoft Medical), a subsidiary of Neusoft Corp is a medical device company that provides medical equipment and services. The company offers medical imaging equipment, e-hospital solutions, regional medical and personal healthcare products. Its product portfoli …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆